RxDoctor Payments Data

Kenan Cetin, PA

Medical · Arcadia, FLNPI 1801864954

Payments from drug & device makers

$576in general payments, 2019–2025

Across 30 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$115
  • AstraZeneca$89
  • GSK$69
  • Bayer$68
  • Novo Nordisk$68
  • Exact Sciences$48
  • plus $120 from 5 others

What the payments were for

  • Food & beverage$576100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$576 in reported general payments places this provider in the 45th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$6,387
Medicare patients
45
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide195$200,757
MounjaroTirzepatide100$115,982
Cosentyx Sensoready (2 Pens)Secukinumab11$79,372
JardianceEmpagliflozin97$76,618
FarxigaDapagliflozin Propanediol54$49,291
JanuviaSitagliptin Phosphate40$39,049
RybelsusSemaglutide27$36,425
Varenicline Tartrate120$33,877
EliquisApixaban20$25,412
Tresiba Flextouch U-200Insulin Degludec37$25,225
XareltoRivaroxaban27$24,337
TrulicityDulaglutide19$19,687
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$19,554
WegovySemaglutide14$19,152
MyrbetriqMirabegron26$17,424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$68$256,333236 claims
Lilly USA, LLCMounjaro, Trulicity$115$135,669119 claims
AstraZenecaFarxiga, Breztri Aerosphere$89$68,84682 claims
Astellas Pharma US IncMyrbetriq$22$17,42426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,031 medical providers in Florida.

Other medical in Arcadia

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →